Reduced taurine transporter expression in lymphoblastoid cell lines from Alzheimer's disease patients compared with age-matched controls: Therapeutic implications?
Yuval Gavriel, Irena Voinsky, Hana Klin, Alessio Squassina, David Gurwitz
The paper measures SLC6A6 mRNA expression in lymphoblastoid cell lines from Alzheimer's disease patients and finds it is 2.8-fold lower than in age-matched controls, suggesting a potential role for taurine in AD pathogenesis.
Drug Development Research · Jul 9, 2025Peer-reviewedGenomics